Can-Fite BioPharma launches best-efforts offering of ADSs and warrants

* Can-Fite BioPharma (NYSE:CANF [https://seekingalpha.com/symbol/CANF]) is offering up to 4.9 million ADSs (representing 1.47 billion ordinary shares) and 4.9 million common warrants in a best-efforts offering.
* Each ADS will be sold with one common warrant at an assumed combined price of $1.02/unit.
* Pre-funded warrants are also offered as an alternative for buyers who would exceed 4.99% (or 9.99%) ownership thresholds post-offering.
* Each pre-funded warrant, priced at $1.019, is exercisable immediately and comes with one common warrant.
* The offering also includes up to 343,138 placement agent qarrants, representing 102.9 million ordinary shares.
* In total, up to 10.1 million ADSs (3.04 billion ordinary shares) may be issued upon full exercise of all warrants.
* All Common Warrants will have a 5-year term and become exercisable upon issuance.
* Source: SEC filing [https://seekingalpha.com/filing/10214653]

MORE ON CAN-FITE BIOPHARMA

* Seeking Alpha’s Quant Rating on Can-Fite Biopharma [https://seekingalpha.com/symbol/CANF/ratings/quant-ratings]
* Historical earnings data for Can-Fite Biopharma [https://seekingalpha.com/symbol/CANF/earnings]
* Financial information for Can-Fite Biopharma [https://seekingalpha.com/symbol/CANF/income-statement]